|
EP2284192A3
(en)
|
2002-11-08 |
2011-07-20 |
Ablynx N.V. |
Camelidae antibodies for sublingual administration
|
|
EP1558647B1
(en)
|
2002-11-08 |
2015-06-10 |
Ablynx N.V. |
Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor
|
|
PT1687338E
(pt)
|
2003-11-07 |
2011-01-20 |
Ablynx Nv |
Anticorpos de domínio único vhh de camelídeos direccionados para o receptor do factor de crescimento epidérmico e suas utilizações
|
|
GB0507044D0
(en)
*
|
2005-04-06 |
2005-05-11 |
Celltech R&D Ltd |
Primers
|
|
GB0507046D0
(en)
*
|
2005-04-06 |
2005-05-11 |
Celltech R&D Ltd |
Primers
|
|
AU2006249144B2
(en)
|
2005-05-18 |
2011-11-17 |
Ablynx Nv |
Improved NanobodiesTM against Tumor Necrosis Factor-alpha
|
|
MX2007014564A
(es)
|
2005-05-20 |
2008-02-07 |
Ablynx Nv |
Anticuerpos de vhh de dominio unico contra el factor de von willebrand.
|
|
EP1999147A1
(en)
*
|
2006-03-27 |
2008-12-10 |
Ablynx N.V. |
Medical delivery device for therapeutic proteins based on single domain antibodies
|
|
CA2660592C
(en)
*
|
2006-05-26 |
2016-07-12 |
Macrogenics, Inc. |
Humanized fc.gamma.riib-specific antibodies and methods of use thereof
|
|
AU2007282023B2
(en)
*
|
2006-08-03 |
2012-09-13 |
Vaccinex, Inc. |
Anti-IL-6 monoclonal antibodies and uses thereof
|
|
SI3028716T1
(sl)
|
2006-10-10 |
2021-01-29 |
Regenesance B.V. |
Komplementarna inhibicija za izboljšano regeneracijo živcev
|
|
AU2007336243B2
(en)
|
2006-12-19 |
2012-07-26 |
Ablynx N.V. |
Amino acid sequences directed against a metalloproteinase from the ADAM family and polypeptides comprising the same for the treatment of ADAM-related diseases and disorders
|
|
CA2673331A1
(en)
|
2006-12-19 |
2008-06-26 |
Ablynx N.V. |
Amino acid sequences directed against gpcrs and polypeptides comprising the same for the treatment of gpcr-related diseases and disorders
|
|
SI2308514T1
(sl)
|
2007-03-23 |
2013-09-30 |
To-Bbb Holding B.V. |
Konjugati za prenos zdravila preko krvno-moĹľganske pregrade
|
|
AU2008270274B2
(en)
|
2007-07-03 |
2012-06-28 |
Ablynx N.V. |
Providing improved immunoglobulin sequences by mutating CDR and/or FR positions
|
|
WO2009068631A1
(en)
|
2007-11-27 |
2009-06-04 |
Ablynx N.V. |
Method for obtaining polypeptide constructs comprising two or more single domain antibodies
|
|
FR2924440B1
(fr)
*
|
2007-12-04 |
2015-01-09 |
Pf Medicament |
Nouveau procede de generation et de criblage d'une banque d'anticorps
|
|
EP2088432A1
(en)
*
|
2008-02-11 |
2009-08-12 |
MorphoSys AG |
Methods for identification of an antibody or a target
|
|
CA2717015A1
(en)
|
2008-03-05 |
2009-09-11 |
Ablynx Nv |
Novel antigen binding dimer-complexes, methods of making and uses thereof
|
|
AU2009235467A1
(en)
|
2008-04-07 |
2009-10-15 |
Ablynx Nv |
Single variable domains against the Notch pathways
|
|
CN102089325A
(zh)
|
2008-04-17 |
2011-06-08 |
埃博灵克斯股份有限公司 |
能够结合血清白蛋白的肽，以及包含其的化合物、构建体和多肽
|
|
NZ589036A
(en)
|
2008-05-16 |
2012-07-27 |
Ablynx Nv |
AMINO ACID SEQUENCES DIRECTED AGAINST CXCR4 AND OTHER GPCRs AND COMPOUNDS COMPRISING THE SAME
|
|
HUE042053T2
(hu)
|
2008-06-05 |
2019-06-28 |
Ablynx Nv |
Vírus burokfehérjéi elleni aminosav-szekvenciák és az azokat tartalmazó polipeptidek virális betegségek kezelésére
|
|
WO2010010119A1
(en)
|
2008-07-22 |
2010-01-28 |
Ablynx Nv |
Amino acid sequences directed against multitarget scavenger receptors and polypeptides
|
|
AU2009329501B2
(en)
|
2008-12-19 |
2015-11-26 |
Ablynx N.V. |
Genetic immunization for producing immunoglobulins against cell-associated antigens such as P2X7, CXCR7 or CXCR4
|
|
WO2010100135A1
(en)
|
2009-03-05 |
2010-09-10 |
Ablynx N.V. |
Novel antigen binding dimer-complexes, methods of making/avoiding and uses thereof
|
|
HUE053480T2
(hu)
|
2009-04-30 |
2021-06-28 |
Ablynx Nv |
Eljárás domén ellenanyagok elõállítására
|
|
WO2010136598A1
(en)
|
2009-05-29 |
2010-12-02 |
Morphosys Ag |
A collection and methods for its use
|
|
US9150640B2
(en)
|
2009-07-10 |
2015-10-06 |
Ablynx N.V. |
Method for the production of variable domains
|
|
LT2805731T
(lt)
|
2009-09-03 |
2019-02-11 |
Ablynx N.V. |
Stabilios polipeptidų kompozicijos ir jų panaudojimas
|
|
US20120321640A1
(en)
|
2009-12-01 |
2012-12-20 |
Ablynx N.V. |
Von willebrand factor specific binding agents and uses thereof
|
|
HRP20251657T1
(hr)
|
2009-12-14 |
2026-02-13 |
Ablynx N.V. |
Imunoglobulinska protutijela s jednostrukom varijabilnom domenom protiv ox40l, konstrukti i njihova terapijska upotreba
|
|
WO2011083141A2
(en)
|
2010-01-08 |
2011-07-14 |
Ablynx Nv |
Method for generation of immunoglobulin sequences by using lipoprotein particles
|
|
CN102781959A
(zh)
|
2010-02-05 |
2012-11-14 |
埃博灵克斯股份有限公司 |
能够结合血清白蛋白的肽和包含所述肽的化合物、构建体和多肽
|
|
US9120855B2
(en)
|
2010-02-10 |
2015-09-01 |
Novartis Ag |
Biologic compounds directed against death receptor 5
|
|
EP2533814A2
(en)
|
2010-02-11 |
2012-12-19 |
Ablynx N.V. |
Delivery of immunoglobulin variable domains and constructs thereof
|
|
ES2738114T3
(es)
|
2010-02-11 |
2020-01-20 |
Ablynx Nv |
Métodos y composiciones para la preparación de aerosoles
|
|
US9101674B2
(en)
|
2010-03-29 |
2015-08-11 |
Vib Vzw |
Targeting and in vivo imaging of tumor-associated macrophages
|
|
US9556273B2
(en)
|
2010-03-29 |
2017-01-31 |
Vib Vzw |
Anti-macrophage mannose receptor single variable domains for targeting and in vivo imaging of tumor-associated macrophages
|
|
MX2012013490A
(es)
|
2010-05-20 |
2013-01-29 |
Ablynx Nv |
Materiales biologicos relacionados con her3.
|
|
WO2011161263A1
(en)
|
2010-06-25 |
2011-12-29 |
Ablynx Nv |
Pharmaceutical compositions for cutaneous administration
|
|
ES2660895T3
(es)
|
2010-10-29 |
2018-03-26 |
Ablynx N.V. |
Método para la producción de dominios variables individuales de inmunoglobulina
|
|
HRP20181811T1
(hr)
|
2010-11-19 |
2018-12-28 |
Morphosys Ag |
Zbirka sljedova protutijela i njezina upotreba
|
|
US9468679B2
(en)
|
2011-03-28 |
2016-10-18 |
Ablynx N.V. |
Method for producing solid formulations comprising immunoglobulin single variable domains
|
|
UA117218C2
(uk)
|
2011-05-05 |
2018-07-10 |
Мерк Патент Гмбх |
Поліпептид, спрямований проти il-17a, il-17f та/або il17-a/f
|
|
US9534039B2
(en)
|
2011-05-09 |
2017-01-03 |
Ablynx N.V. |
Method for the production of immunoglobulin single variable domains
|
|
KR102072250B1
(ko)
|
2011-05-27 |
2020-03-02 |
아블린쓰 엔.브이. |
Ｒａｎｋｌ 결합 펩티드를 이용한 골 재흡수 억제
|
|
US9580480B2
(en)
|
2011-05-31 |
2017-02-28 |
Massachusetts Institute Of Technology |
Cell-directed synthesis of multifunctional nanopatterns and nanomaterials
|
|
JP2014525736A
(ja)
|
2011-06-23 |
2014-10-02 |
アブリンクス エン．ヴェー． |
ＩｇＥに対する免疫グロブリン単一可変ドメイン
|
|
EP2747782B1
(en)
|
2011-09-23 |
2018-01-17 |
Ablynx NV |
Prolonged inhibition of interleukin-6 mediated signaling
|
|
AU2013265665B2
(en)
|
2012-05-24 |
2017-10-26 |
Vib Vzw |
Anti-macrophage mannose receptor single variable domains for targeting and in vivo imaging of tumor-associated macrophages
|
|
US11339208B1
(en)
|
2012-05-31 |
2022-05-24 |
United States Of America As Represented By The Secretary Of The Air Force |
Camelidae single-domain antibodies against Yersinia pestis and methods of use
|
|
WO2014087010A1
(en)
|
2012-12-07 |
2014-06-12 |
Ablynx N.V. |
IMPROVED POLYPEPTIDES DIRECTED AGAINST IgE
|
|
CN112858672A
(zh)
|
2013-01-30 |
2021-05-28 |
弗拉芒区生物技术研究所 |
用于筛选和药物发现目的的新型嵌合多肽
|
|
PL2953973T3
(pl)
|
2013-02-05 |
2020-01-31 |
Vib Vzw |
Środki wiążące muskarynowy receptor acetylocholiny i ich zastosowania
|
|
WO2014140376A1
(en)
|
2013-03-15 |
2014-09-18 |
Vib Vzw |
Anti-macrophage mannose receptor single variable domains for use in cardiovascular diseases
|
|
JP6967347B2
(ja)
|
2013-04-29 |
2021-11-17 |
バイオタリス・エン・フェー |
スフィンゴ脂質に結合する抗体を含む農薬組成物
|
|
NL1040254C2
(en)
|
2013-05-17 |
2014-11-24 |
Ablynx Nv |
Stable formulations of immunoglobulin single variable domains and uses thereof.
|
|
EP2883883A1
(en)
|
2013-12-16 |
2015-06-17 |
Cardio3 Biosciences S.A. |
Therapeutic targets and agents useful in treating ischemia reperfusion injury
|
|
CA2936728C
(en)
|
2014-01-30 |
2023-06-20 |
Vib Vzw |
Opioid receptor binding agents and uses thereof
|
|
NL2013661B1
(en)
|
2014-10-21 |
2016-10-05 |
Ablynx Nv |
KV1.3 Binding immunoglobulins.
|
|
WO2016012363A1
(en)
|
2014-07-22 |
2016-01-28 |
Vib Vzw |
Methods to select for agents that stabilize protein complexes
|
|
JP6289733B2
(ja)
|
2014-07-29 |
2018-03-07 |
フレイエ ユニヴェルシテイト ブリュッセルＶｒｉｊｅ Ｕｎｉｖｅｒｓｉｔｅｉｔ Ｂｒｕｓｓｅｌ |
癌の予防及び／又は治療に用いるための放射標識抗体断片
|
|
US20180036442A1
(en)
|
2014-07-29 |
2018-02-08 |
Vrije Universiteit Brussel |
Radio-labelled antibody fragments for use in the prognosis, diagnosis of cancer as well as for the prediction of cancer therapy response
|
|
US9938522B2
(en)
|
2014-09-25 |
2018-04-10 |
Genewiz, Inc. |
High throughput sequencing of end regions of long linear DNAs
|
|
AR102550A1
(es)
|
2014-11-05 |
2017-03-08 |
Agrosavfe Nv |
Planta transgénica que comprende un polinucleótido que codifica un dominio variable de anticuerpo de cadena pesada
|
|
CN107406497A
(zh)
|
2014-12-19 |
2017-11-28 |
埃博灵克斯股份有限公司 |
半胱氨酸连接的纳米抗体二聚体
|
|
WO2017013026A1
(en)
|
2015-07-17 |
2017-01-26 |
Vrije Universiteit Brussel |
Radiolabelled antibody fragments for use in treating cancer
|
|
CN108473561B
(zh)
|
2015-11-27 |
2022-12-16 |
埃博灵克斯股份有限公司 |
抑制cd40l的多肽
|
|
US11243214B2
(en)
|
2016-04-22 |
2022-02-08 |
Université Libre de Bruxelles |
Biomarker expressed in pancreatic beta cells useful in imaging or targeting beta cells
|
|
WO2017182605A1
(en)
|
2016-04-22 |
2017-10-26 |
Université Libre de Bruxelles |
A new biomarker expressed in pancreatic beta cells useful in imaging or targeting beta cells
|
|
CA3022697A1
(en)
|
2016-05-02 |
2017-11-09 |
Ablynx Nv |
Treatment of rsv infection
|
|
WO2018007442A1
(en)
|
2016-07-06 |
2018-01-11 |
Ablynx N.V. |
Treatment of il-6r related diseases
|
|
WO2018029182A1
(en)
|
2016-08-08 |
2018-02-15 |
Ablynx N.V. |
Il-6r single variable domain antibodies for treatment of il-6r related diseases
|
|
US11098113B2
(en)
|
2016-09-15 |
2021-08-24 |
Vib Vzw |
Immunoglobulin single variable domains directed against macrophage migration inhibitory factor
|
|
IL317416A
(en)
|
2016-11-16 |
2025-02-01 |
Ablynx Nv |
T cell-recruiting polypeptides capable of binding CD123 and TCR alpha/beta
|
|
WO2018099968A1
(en)
|
2016-11-29 |
2018-06-07 |
Ablynx N.V. |
Treatment of infection by respiratory syncytial virus (rsv)
|
|
BR112019017853A2
(pt)
|
2017-02-28 |
2021-04-27 |
Vib Vzw |
Meios e métodos para liberação oral de proteína
|
|
EP3612648A1
(en)
|
2017-04-18 |
2020-02-26 |
Université Libre de Bruxelles |
Biomarkers and targets for proliferative diseases
|
|
CA3062238A1
(en)
|
2017-05-11 |
2018-11-15 |
Vib Vzw |
Glycosylation of variable immunoglobulin domains
|
|
CN111032695B
(zh)
|
2017-06-02 |
2024-06-25 |
默克专利股份有限公司 |
结合adamts的免疫球蛋白
|
|
MX2019014397A
(es)
|
2017-06-02 |
2020-02-10 |
Merck Patent Gmbh |
Polipeptidos que enlazan adamts5, mmp13 y agrecano.
|
|
MX2019014504A
(es)
|
2017-06-02 |
2020-07-20 |
Merck Patent Gmbh |
Inmunoglobulinas de union a agrecano.
|
|
CN110997001A
(zh)
|
2017-06-02 |
2020-04-10 |
默克专利股份有限公司 |
Mmp13结合免疫球蛋白
|
|
CA3070253A1
(en)
|
2017-07-19 |
2019-01-24 |
Vib Vzw |
Serum albumin binding agents
|
|
EP4635987A3
(en)
|
2017-10-31 |
2026-01-14 |
Vib Vzw |
Novel antigen-binding chimeric proteins and methods and uses thereof
|
|
WO2019155041A1
(en)
|
2018-02-12 |
2019-08-15 |
Vib Vzw |
Gβγ COMPLEX ANTIBODIES AND USES THEREOF
|
|
EP3758742A1
(en)
|
2018-03-01 |
2021-01-06 |
Vrije Universiteit Brussel |
Human pd-l1-binding immunoglobulins
|
|
JP7390729B2
(ja)
|
2018-03-23 |
2023-12-04 |
ユニヴェルシテ リブル ドゥ ブリュッセル |
Ｗｎｔシグナル伝達アゴニスト分子
|
|
MX2020010091A
(es)
|
2018-03-27 |
2021-01-15 |
Umc Utrecht Holding Bv |
Trombolisis direccionada para tratamiento de trombosis microvascular.
|
|
CN114041057A
(zh)
|
2019-04-29 |
2022-02-11 |
康福治疗有限公司 |
嵌合蛋白和筛选与gpcr结合的化合物和配体的方法
|
|
US20220289837A1
(en)
|
2019-04-30 |
2022-09-15 |
Vib Vzw |
Cystic Fibrosis Transmembrane Conductance Regulator Stabilizing Agents
|
|
WO2020239934A1
(en)
|
2019-05-28 |
2020-12-03 |
Vib Vzw |
Cd8+ t-cells lacking plexins and their application in cancer treatment
|
|
EP3976650A1
(en)
|
2019-05-28 |
2022-04-06 |
Vib Vzw |
Cancer treatment by targeting plexins in the immune compartment
|
|
EP4048703A1
(en)
|
2019-10-21 |
2022-08-31 |
Vib Vzw |
Nanodisc-specific antigen-binding chimeric proteins
|
|
IL292879B2
(en)
|
2019-11-11 |
2025-08-01 |
Ibi Ag Innovative Bio Insecticides Ltd |
Nanoantibodies for insect control and their uses
|
|
EP4065603A1
(en)
|
2019-11-27 |
2022-10-05 |
Vib Vzw |
Positive allosteric modulators of the calcium-sensing receptor
|
|
GB201918279D0
(en)
|
2019-12-12 |
2020-01-29 |
Vib Vzw |
Glycosylated single chain immunoglobulin domains
|
|
EP4077372A1
(en)
|
2019-12-20 |
2022-10-26 |
Vib Vzw |
Nanobody exchange chromatography
|
|
WO2021140205A1
(en)
|
2020-01-10 |
2021-07-15 |
Confo Therapeutics N.V. |
Methods for generating antibodies and antibody fragments and libraries comprising same
|
|
WO2021156490A2
(en)
|
2020-02-06 |
2021-08-12 |
Vib Vzw |
Corona virus binders
|
|
JP7814714B2
(ja)
|
2020-02-25 |
2026-02-17 |
ブイアイビー ブイゼットダブリュ |
ロイシンリッチリピートキナーゼ２のアロステリック調節因子
|
|
EP4125379B1
(en)
|
2020-03-31 |
2024-08-21 |
Biotalys NV |
Anti-fungal polypeptides
|
|
CN113527488B
(zh)
|
2020-04-22 |
2026-04-17 |
迈威(上海)生物科技股份有限公司 |
一种靶向人程序性死亡配体1（pd-l1）的单可变域抗体及其衍生物
|
|
WO2021229104A1
(en)
|
2020-05-15 |
2021-11-18 |
Université de Liège |
Anti-cd38 single-domain antibodies in disease monitoring and treatment
|
|
WO2022003156A1
(en)
|
2020-07-02 |
2022-01-06 |
Oncurious Nv |
Ccr8 non-blocking binders
|
|
WO2022023583A1
(en)
|
2020-07-31 |
2022-02-03 |
Biotalys NV |
Expression host
|
|
WO2022063957A1
(en)
|
2020-09-24 |
2022-03-31 |
Vib Vzw |
Biomarker for anti-tumor therapy
|
|
WO2022063947A1
(en)
|
2020-09-24 |
2022-03-31 |
Vib Vzw |
Combination of p2y6 inhibitors and immune checkpoint inhibitors
|
|
WO2022063984A1
(en)
|
2020-09-25 |
2022-03-31 |
Ablynx Nv |
Polypeptides comprising immunoglobulin single variable domains targeting il-13 and ox40l
|
|
WO2022117569A1
(en)
|
2020-12-02 |
2022-06-09 |
Oncurious Nv |
A ccr8 antagonist antibody in combination with a lymphotoxin beta receptor agonist antibody in therapy against cancer
|
|
EP4255929A2
(en)
|
2020-12-02 |
2023-10-11 |
Vib Vzw |
An ltbr agonist in combination therapy against cancer
|
|
JP7842101B2
(ja)
|
2020-12-18 |
2026-04-07 |
アブリンクス エン．ヴェー． |
ＩＬ－６およびＴＮＦ－αを標的化する免疫グロブリン単一可変ドメインを含むポリペプチド
|
|
GB202020502D0
(en)
|
2020-12-23 |
2021-02-03 |
Vib Vzw |
Antibody composistion for treatment of corona virus infection
|
|
EP4267617A1
(en)
|
2020-12-24 |
2023-11-01 |
Vib Vzw |
Human ccr8 binders
|
|
EP4267621A1
(en)
|
2020-12-24 |
2023-11-01 |
Vib Vzw |
Murine cross-reactive human ccr8 binders
|
|
US20240052044A1
(en)
|
2020-12-24 |
2024-02-15 |
Vib Vzw |
Non-blocking human ccr8 binders
|
|
CN117794566A
(zh)
|
2021-02-05 |
2024-03-29 |
Vib研究所 |
沙贝病毒结合剂
|
|
CA3207548A1
(en)
|
2021-02-05 |
2022-08-11 |
Xavier Saelens |
Sarbecovirus binders
|
|
EP4294407A1
(en)
|
2021-02-17 |
2023-12-27 |
Vib Vzw |
Inhibition of slc4a4 in the treatment of cancer
|
|
IL305318A
(en)
|
2021-02-19 |
2023-10-01 |
Vib Vzw |
Cation-independent mannose-6-phosphate receptor binders
|
|
CN117321076A
(zh)
|
2021-02-19 |
2023-12-29 |
美国卫生及公众服务部代表 |
中和SARS-CoV-2的单结构域抗体
|
|
WO2022199804A1
(en)
|
2021-03-24 |
2022-09-29 |
Vib Vzw |
Nek6 inhibition to treat als and ftd
|
|
US20240261446A1
(en)
|
2021-05-17 |
2024-08-08 |
Université de Liège |
Anti-cd38 single domain antibodies in disease monitoring and treatment
|
|
WO2022268993A1
(en)
|
2021-06-23 |
2022-12-29 |
Vib Vzw |
Means and methods for selection of specific binders
|
|
US20240343811A1
(en)
|
2021-06-29 |
2024-10-17 |
Shandong Simcere Biopharmacutical Co., Ltd. |
Cd16 antibody and use thereof
|
|
WO2023016828A2
(en)
|
2021-07-30 |
2023-02-16 |
Vib Vzw |
Cation-independent mannose-6-phosphate receptor binders for targeted protein degradation
|
|
EP4378954A4
(en)
|
2021-07-30 |
2025-05-21 |
Shandong Simcere Biopharmaceutical Co., Ltd. |
Anti-pvrig/anti-tigit bispecific antibody and application
|
|
WO2023057601A1
(en)
|
2021-10-06 |
2023-04-13 |
Biotalys NV |
Anti-fungal polypeptides
|
|
CN118696058A
(zh)
|
2021-12-03 |
2024-09-24 |
山东先声生物制药有限公司 |
抗bcma纳米抗体及其应用
|
|
AU2022409733A1
(en)
|
2021-12-17 |
2024-08-01 |
Ablynx Nv |
POLYPEPTIDES COMPRISING IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS TARGETING TCRαβ, CD33 AND CD123
|
|
US20250145705A1
(en)
|
2021-12-31 |
2025-05-08 |
Shandong Simcere Biopharmaceutical Co., Ltd. |
Gprc5d antibody and application thereof
|
|
CA3248241A1
(en)
|
2022-01-12 |
2023-07-20 |
Vib Vzw |
HUMAN NTCP BINDERS FOR THERAPEUTIC USE AND TARGETED LIVER ADMINISTRATION
|
|
EP4473108A1
(en)
|
2022-02-02 |
2024-12-11 |
Biotalys NV |
Methods for genome editing
|
|
EP4476250A1
(en)
|
2022-02-07 |
2024-12-18 |
Vib Vzw |
Engineered stabilizing aglycosylated fc-regions
|
|
US20250235534A1
(en)
|
2022-04-13 |
2025-07-24 |
Vib Vzw |
An LTBR Agonist In Combination Therapy Against Cancer
|
|
EP4519324A1
(en)
|
2022-05-02 |
2025-03-12 |
UMC Utrecht Holding B.V. |
Single domain antibodies for the detection of plasmin-cleaved vwf
|
|
EP4526340A1
(en)
|
2022-05-18 |
2025-03-26 |
Vib Vzw |
Sarbecovirus spike s2 subunit binders
|
|
KR20250021313A
(ko)
|
2022-06-06 |
2025-02-12 |
산둥심시어 바이오파마슈티칼 씨오., 엘티디. |
Bcma, gprc5d 및 t 세포를 표적으로 하는 다중특이적 항체 및 그 응용
|
|
JP2025523630A
(ja)
|
2022-07-04 |
2025-07-23 |
ブイアイビー ブイゼットダブリュ |
血液－脳脊髄液関門通過抗体
|
|
EP4594348A1
(en)
|
2022-09-27 |
2025-08-06 |
Vib Vzw |
Antivirals against human parainfluenza virus
|
|
WO2024083843A1
(en)
|
2022-10-18 |
2024-04-25 |
Confo Therapeutics N.V. |
Amino acid sequences directed against the melanocortin 4 receptor and polypeptides comprising the same for the treatment of mc4r-related diseases and disorders
|
|
WO2024105091A1
(en)
|
2022-11-15 |
2024-05-23 |
Imec Vzw |
Method and system for droplet manipulation
|
|
US20240200085A1
(en)
|
2022-12-15 |
2024-06-20 |
Aarhus Universitet |
Synthetic activation of multimeric transmembrane receptors
|
|
WO2024133937A1
(en)
|
2022-12-22 |
2024-06-27 |
Biotalys NV |
Methods for genome editing
|
|
US20260026500A1
(en)
|
2022-12-29 |
2026-01-29 |
Biotalys NV |
Agrochemical compositions
|
|
EP4642916A2
(en)
|
2022-12-30 |
2025-11-05 |
Biotalys NV |
Secretion signals
|
|
WO2024141638A1
(en)
|
2022-12-30 |
2024-07-04 |
Biotalys NV |
Self-emulsifiable concentrate
|
|
EP4642233A1
(en)
|
2022-12-30 |
2025-11-05 |
Biotalys NV |
Agglomerate
|
|
WO2024156888A1
(en)
|
2023-01-27 |
2024-08-02 |
Vib Vzw |
Cd163-binding conjugates
|
|
EP4655323A1
(en)
|
2023-01-27 |
2025-12-03 |
Vrije Universiteit Brussel |
Cd8b-binding polypeptides
|
|
WO2024165710A1
(en)
|
2023-02-09 |
2024-08-15 |
Seni-Preps B.V. |
Immunoglobulin single variable domains that inhibit urease and use thereof
|
|
WO2024175787A1
(en)
|
2023-02-24 |
2024-08-29 |
Vrije Universiteit Brussel |
Anti-inflammatory pannexin 1 channel inhibitors
|
|
AU2024236537A1
(en)
|
2023-03-14 |
2025-09-04 |
Aarhus Universitet |
Genetically altered nfr5 receptor kinases
|
|
WO2024208816A1
(en)
|
2023-04-03 |
2024-10-10 |
Vib Vzw |
Blood-brain barrier crossing antibodies
|
|
CN121511260A
(zh)
|
2023-05-11 |
2026-02-10 |
非营利性组织佛兰芒综合大学生物技术研究所 |
SLC4A4/NBCe1抑制剂
|
|
AU2024276787A1
(en)
|
2023-05-23 |
2026-01-15 |
Allygen Group |
Pd-l1 and trop-2 targeting conjugates comprising effector molecules and uses thereof
|
|
WO2024261344A1
(en)
|
2023-06-23 |
2024-12-26 |
Vib Vzw |
Novel binders targeting the multi-drug resistant pathogen acinetobacter baumannii
|
|
EP4483951A1
(en)
|
2023-06-30 |
2025-01-01 |
Université de Liège |
Single-domain antibody for inhibition of neutrophil elastase activity
|
|
NL2036011B1
(en)
|
2023-10-12 |
2025-04-30 |
Synapse Res Institute |
Molecules for reversing anti-coagulant activity of direct oral anticoagulants
|
|
WO2025093683A1
(en)
|
2023-11-03 |
2025-05-08 |
Neuvasq Biotechnologies Sa |
Wnt7 signaling agonists
|
|
WO2025109176A1
(en)
|
2023-11-22 |
2025-05-30 |
Exevir Bio Bv |
Optimized sarbecovirus spike s2 subunit binders and compositions comprising the same
|
|
WO2025125577A1
(en)
|
2023-12-14 |
2025-06-19 |
Vib Vzw |
Antibodies against influenza b virus
|
|
US12378306B2
(en)
|
2023-12-22 |
2025-08-05 |
Biotalys NV |
Anti-fungal VHH antibodies
|
|
WO2025154056A1
(en)
|
2024-01-21 |
2025-07-24 |
Ibi-Ag Innovative Bio Insecticides Ltd. |
Anti-insect cda nanobodies and uses thereof
|
|
WO2025154058A1
(en)
|
2024-01-21 |
2025-07-24 |
Ibi-Ag Innovative Bio Insecticides Ltd. |
Anti-insect hsp70 nanobodies and uses thereof
|
|
WO2025181155A1
(en)
|
2024-02-26 |
2025-09-04 |
Vib Vzw |
Human beta-glucocerebrosidase binders and uses thereof
|
|
WO2025196308A1
(en)
|
2024-03-22 |
2025-09-25 |
Vib Vzw |
Means and methods for displaying fc-containing proteins on cells and selection thereof
|
|
WO2025219231A1
(en)
|
2024-04-15 |
2025-10-23 |
Vib Vzw |
Computer-implemented means and methods for the de novo design of antibodies targeting a specific epitope
|
|
WO2025238157A1
(en)
|
2024-05-15 |
2025-11-20 |
Katholieke Universiteit Leuven |
Multispecific binding agent suitable for use in cancer immune therapy
|
|
WO2026008665A1
(en)
|
2024-07-01 |
2026-01-08 |
Vib Vzw |
Binders of the pd-1•pd-l1 complex and their use
|
|
WO2026008785A1
(en)
|
2024-07-03 |
2026-01-08 |
Biotalys NV |
Agrochemical compositions
|
|
WO2026027659A1
(en)
|
2024-07-31 |
2026-02-05 |
Seni-Preps B.V. |
Improved immunoglobulin single variable domains that inhibit urease and use thereof
|
|
WO2026068859A1
(en)
|
2024-09-30 |
2026-04-02 |
Université Libre de Bruxelles |
Wnt signaling agonist molecules in the treatment of a bone-related disease or disorder
|
|
WO2026087355A1
(en)
|
2024-10-22 |
2026-04-30 |
Biotalys NV |
Downstream processing
|